Literature DB >> 12043561

Management of children after presenting to hospital with acute asthma but not requiring admission.

E Comino1, N Zwar, M Harris.   

Abstract

OBJECTIVE: To examine the treatment of asthma in children aged 4-15 years in the 12 months following presentation to hospital with acute asthma but not requiring admission.
METHOD: Questionnaire based survey addressing the child's use of health services, contact with general practitioners before presentation, use of asthma management plans, symptom frequency, and management of asthma.
RESULTS: Sixty-six parents (response rate 50%) completed questionnaires. Children usually experienced infrequent episodic symptoms of asthma, and had good or excellent health (68%). Twenty-two children reported no medical follow up post-emergency department (ED). Of the 39 children who had been reviewed by their GP post-ED, 51% (n = 20) recalled discussing the reasons for presentation to ED with the GP, 41% (n = 16) had a lung function measurement and 64% (n = 25) had discussed ways to better manage the child's asthma to avoid the need for future ED attendance. Most parents of children with asthma (n = 57, 86%) recalled the GP explaining how to manage their child's asthma, but only 35 (61.4%) recalled the GP ever writing down these instructions.
CONCLUSION: Children with acute asthma who do not require admission may be better managed in the community if there is greater recourse to GP care, use of written management guidelines and opportunities for additional community care are taken up. Further work is needed to identify strategies that will enable GPs to do this.

Entities:  

Mesh:

Year:  2002        PMID: 12043561

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  1 in total

1.  Development and evaluation of an instrument to measure reasoning about managing asthma in older school-age children and adolescents.

Authors:  Eileen Kintner; Gwendolyn Cook; Lakisha Hull; Linda Meeder
Journal:  J Nurs Meas       Date:  2013
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.